Decoding Apelin: Its Role in Metabolic Programming, Fetal Growth, and Gestational Complications
Children · 21.10.2024 · 11 (10) · 1270
DOI: 10.3390/children11101270 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Children, online erschienen am 21.10.2024. Verfasst von Nikolaos Loukas und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Tzaneio General Hospital, 185 36 Piraeus, Greece. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 69 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Placental insufficiency and gestational diabetes, which are both serious pregnancy complications, are linked to altered fetal growth, whether restricted or excessive, and result in metabolic dysfunction, hypoxic/oxidative injury, and adverse perinatal outcomes. Although much research has been carried out in this field, the underlying pathogenetic mechanisms have not as yet been fully elucidated. Particularly because of the role it plays in cardiovascular performance, glucose metabolism, inflammation, and oxidative stress, the adipokine apelin was recently shown to be a potential regulator of fetal growth and metabolic programming. This review investigated the numerous biological actions of apelin in utero and aimed to shed more light on its role in fetal growth and metabolic programming. The expression of the apelinergic system in a number of tissues indicates its involvement in many physiological mechanisms, including angiogenesis, cell proliferation, energy metabolism, inflammation, and oxidative stress. Moreover, it appears that apelin has a major function in disorders such as diabetes mellitus, fetal growth abnormalities, fetal hypoxia, and preeclampsia. We herein describe in detail the regulatory effects exerted by the adipokine apelin on fetal growth and metabolic programming while stressing the necessity for additional research into the therapeutic potential of apelin and its mechanisms of action in pregnancy-related disorders.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Obstetrics and Gynecology, Tzaneio General Hospital, 185 36 Piraeus, Greece.
- Third Department of Obstetrics and Gynecology, University General Hospital "ATTIKON", Medical School, National and Kapodistrian University of Athens, 124 62 Athens, Greece.
- Department of Obstetrics and Gynecology, University of Patras, 265 04 Patras, Greece.
- Department of Obstetrics and Gynecology, Santorini General Hospital, 847 00 Thira, Greece.
- Vascular Biology, Molecular and Clinical Sciences Research Institute, St George's University of London, London SW17 0RE, UK.
ORCID-Profile: Dionysios Vrachnis, Nikolaos Antonakopoulos, Alexandros Fotiou, Chryssi Christodoulaki, Anastasios Potiris, Nikolaos Vrachnis
Zitieren
APA
Loukas, N., Vrachnis, D., Antonakopoulos, N., Stavros, S., Machairiotis, N., Fotiou, A., Christodoulaki, C., Lolos, M., Maroudias, G., Potiris, A., Drakakis, P., & Vrachnis, N. (2024). Decoding Apelin: Its Role in Metabolic Programming, Fetal Growth, and Gestational Complications. Children, 11(10), 1270. https://doi.org/10.3390/children11101270
Vancouver
Loukas N, Vrachnis D, Antonakopoulos N, Stavros S, Machairiotis N, Fotiou A, et al. Decoding Apelin: Its Role in Metabolic Programming, Fetal Growth, and Gestational Complications. Children. 2024;11(10):1270. doi:10.3390/children11101270
BibTeX
@article{Loukas2024,
author = {Loukas, Nikolaos and Vrachnis, Dionysios and Antonakopoulos, Nikolaos and Stavros, Sofoklis and Machairiotis, Nikolaos and Fotiou, Alexandros and Christodoulaki, Chryssi and Lolos, Markos and Maroudias, Georgios and Potiris, Anastasios and Drakakis, Petros and Vrachnis, Nikolaos},
title = {Decoding Apelin: Its Role in Metabolic Programming, Fetal Growth, and Gestational Complications},
journal = {Children},
year = {2024},
volume = {11},
number = {10},
pages = {1270},
doi = {10.3390/children11101270}
}
EUVIMED